Company / Working Capital
Johnson & Johnson Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.5B
FY2025
5-year range
-$508.0M / $15.8B
FY2021-FY2025
Trend
-73.1%
vs FY2024
Sector context
#29 of 213
Health Care
What the data says
Johnson & Johnson's working capital of $1.5B is higher than 86% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from -$508M in FY2022 to $38.7B in FY2016.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 5-year CAGR of -29.7%. Top quartile in the Health Care sector.
Declined from $7.2B to $1.5B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -29.7%
- 10-Year CAGR
- -
Sector benchmark
+60.3% above sector average
Key checks
Key Insights
- 5-year CAGR of -29.7%, indicating a declining trend.
- In FY2025, working capital decreased 73.1% year-over-year.
- Ranks #29 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | -73.1% |
| FY2024 | $5.6B | -22.8% |
| FY2023 | $7.2B | +1519.9% |
| FY2022 | -$508.0M | -103.2% |
| FY2021 | $15.8B | +80.2% |
| FY2020 | $8.7B | -6.1% |
| FY2019 | $9.3B | -37.1% |
| FY2018 | $14.8B | +17.9% |
| FY2017 | $12.6B | -67.6% |
| FY2016 | $38.7B | +19.4% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026